Cambridge UK pharma company Bicycle Therapeutics has unveiled a sensational $555 million investment haul on the US’s NASDAQ market. Cambridge property heavyweight Bidwells plans to hire an additional 200-250 people and double the size of its business by 2030. The 185-year-old company also intends to grow the scope of its operations through expansion into different sectors and regions of the UK and
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く